About
James McCully is a biomedical researcher known for pioneering Therapeutic Mitochondria Transplantation (TMT), a mitochondrial medicine approach aimed at treating ischemia-reperfusion injury and related conditions. He is a co-founder of cellvie, which was established to translate his Harvard Medical School research into clinical products, including applications in organ transplantation and aging. Public coverage also identifies him as an associate professor of surgery at Boston Children's Hospital.
Areas of interest
biotechmitochondrial medicinetransplantationcardioprotectionischemia-reperfusion injuryorgan salvageaginglongevity